These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 30929731)

  • 21. Fresh versus elective frozen embryo transfer in IVF/ICSI cycles: a systematic review and meta-analysis of reproductive outcomes.
    Roque M; Haahr T; Geber S; Esteves SC; Humaidan P
    Hum Reprod Update; 2019 Jan; 25(1):2-14. PubMed ID: 30388233
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Corifollitropin alfa: a review of its use in controlled ovarian stimulation for assisted reproduction.
    Croxtall JD; McKeage K
    BioDrugs; 2011 Aug; 25(4):243-54. PubMed ID: 21815699
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ovarian stimulation with corifollitropin alfa followed by hp-hMG compared to hp-hMG in patients at risk of poor ovarian response undergoing ICSI: A randomized controlled trial.
    Taronger R; Martínez-Cuenca S; Ferreros I; Rubio JM; Fernández-Colom PJ; Martínez-Triguero ML; Pellicer A
    Eur J Obstet Gynecol Reprod Biol; 2018 Dec; 231():192-197. PubMed ID: 30428403
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The effect of growth hormone supplementation in poor ovarian responders undergoing IVF or ICSI: a meta-analysis of randomized controlled trials.
    Yang P; Wu R; Zhang H
    Reprod Biol Endocrinol; 2020 Jul; 18(1):76. PubMed ID: 32727608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy and safety of frozen-thawed embryo transfer in women aged 35 to 42 years from the PURSUE randomized clinical trial.
    Boostanfar R; Gates D; Guan Y; Gordon K; McCrary Sisk C; Stegmann BJ
    Fertil Steril; 2016 Aug; 106(2):300-305.e5. PubMed ID: 27090863
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Addition of highly purified HMG after corifollitropin alfa in antagonist-treated poor ovarian responders: a pilot study.
    Polyzos NP; De Vos M; Corona R; Vloeberghs V; Ortega-Hrepich C; Stoop D; Tournaye H
    Hum Reprod; 2013 May; 28(5):1254-60. PubMed ID: 23442756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Progestin primed ovarian stimulation using corifollitropin alfa in PCOS women effectively prevents LH surge and reduces injection burden compared to GnRH antagonist protocol.
    Huang TC; Huang MZ; Seow KM; Yang IJ; Pan SP; Chen MJ; Hwang JL; Chen SU
    Sci Rep; 2021 Nov; 11(1):22732. PubMed ID: 34815477
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Urinary hMG versus recombinant FSH for controlled ovarian hyperstimulation following an agonist long down-regulation protocol in IVF or ICSI treatment: a systematic review and meta-analysis.
    Coomarasamy A; Afnan M; Cheema D; van der Veen F; Bossuyt PM; van Wely M
    Hum Reprod; 2008 Feb; 23(2):310-5. PubMed ID: 18056719
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Is corifollitropin alfa effective in controlled ovarian stimulation among all poor ovarian responders? A retrospective comparative study.
    Andrisani A; Marin L; Ragazzi E; Donà G; Bordin L; Dessole F; Armanini D; Esposito F; Vitagliano A; Sabbadin C; Ambrosini G
    Gynecol Endocrinol; 2019 Oct; 35(10):894-898. PubMed ID: 31081709
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Feasibility of corifollitropin alfa/GnRH antagonist protocol combined with GnRH agonist triggering and freeze-all strategy in polycystic ovary syndrome patients.
    Hwang JL; Chen SU; Chen HJ; Chen HF; Yang YS; Chang CH; Seow KM; Tzeng CR; Lin YH
    J Formos Med Assoc; 2018 Jun; 117(6):535-540. PubMed ID: 28830648
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Low dosing of gonadotropins in in vitro fertilization cycles for women with poor ovarian reserve: systematic review and meta-analysis.
    Youssef MA; van Wely M; Mochtar M; Fouda UM; Eldaly A; El Abidin EZ; Elhalwagy A; Mageed Abdallah AA; Zaki SS; Abdel Ghafar MS; Mohesen MN; van der Veen F
    Fertil Steril; 2018 Feb; 109(2):289-301. PubMed ID: 29317127
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
    Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
    Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Corifollitropin alfa versus recombinant follicle-stimulating hormone: an individual patient data meta-analysis.
    Griesinger G; Boostanfar R; Gordon K; Gates D; McCrary Sisk C; Stegmann BJ
    Reprod Biomed Online; 2016 Jul; 33(1):56-60. PubMed ID: 27178762
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Administration of corifollitropin alfa on Day 2 versus Day 4 of the cycle in a GnRH antagonist protocol: a randomized controlled pilot study.
    Blockeel C; Polyzos NP; Derksen L; De Brucker M; Vloeberghs V; van de Vijver A; De Vos M; Tournaye H
    Hum Reprod; 2014 Jul; 29(7):1500-7. PubMed ID: 24813196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Risk of severe ovarian hyperstimulation syndrome in GnRH antagonist versus GnRH agonist protocol: RCT including 1050 first IVF/ICSI cycles.
    Toftager M; Bogstad J; Bryndorf T; Løssl K; Roskær J; Holland T; Prætorius L; Zedeler A; Nilas L; Pinborg A
    Hum Reprod; 2016 Jun; 31(6):1253-64. PubMed ID: 27060174
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mild versus conventional ovarian stimulation for IVF in poor, normal and hyper-responders: a systematic review and meta-analysis.
    Datta AK; Maheshwari A; Felix N; Campbell S; Nargund G
    Hum Reprod Update; 2021 Feb; 27(2):229-253. PubMed ID: 33146690
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Corifollitropin alfa in women stimulated for the first time in in vitro fertilization programme].
    Vraná-Mardešićová N; Vobořil J; Melicharová L; Jelínková L; Vilímová Š; Mardešić T
    Ceska Gynekol; 2017; 82(5):362-365. PubMed ID: 29020783
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Performance of prognostic modelling of high and low ovarian response to ovarian stimulation for IVF.
    Scheinhardt MO; Lerman T; König IR; Griesinger G
    Hum Reprod; 2018 Aug; 33(8):1499-1505. PubMed ID: 30007353
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High ovarian response does not jeopardize ongoing pregnancy rates and increases cumulative pregnancy rates in a GnRH-antagonist protocol.
    Fatemi HM; Doody K; Griesinger G; Witjes H; Mannaerts B
    Hum Reprod; 2013 Feb; 28(2):442-52. PubMed ID: 23136144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Monitoring of stimulated cycles in assisted reproduction (IVF and ICSI).
    Kwan I; Bhattacharya S; McNeil A; van Rumste MM
    Cochrane Database Syst Rev; 2008 Apr; (2):CD005289. PubMed ID: 18425917
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.